Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 850807 | Other Identifier | University of Pennsylvania IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This randomized controlled trial will assess the effects on quality of life of two approaches to symptom management among new patients referred to a palliative care oncology clinic.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Participants in this group will consent to participate in a study about quality of life for patients with cancer seeking outpatient palliative care. They will be seen in a palliative care oncology clinic at which time they will be offered additional resources to promote symptom management. They will be asked to complete a series of surveys every two weeks for 16 weeks which will assess their quality of life, symptoms, and medication use. |
|
| Usual Care | No Intervention | Participants in this group will consent to participate in a study about quality of life for patients with cancer seeking outpatient palliative care. They will be seen in a palliative care oncology clinic where they will receive symptom management and supportive care. They will be asked to complete a series of surveys every two weeks for 16 weeks which will assess their quality of life, symptoms, and medication use. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Offering Additional Resources to Promote Symptom Management | Behavioral | Participants will be offered additional resources to promote symptom management. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life - McGill Quality of Life Questionnaire | Quality of life will be measured through the McGill Quality of Life Questionnaire Revised (MQOL-R). The questionnaire is 15 questions assessing overall and specific areas of quality of life. | Baseline - 16 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of Accessing Additional Resources for Symptom Management | Feasibility will be measured by whether participants accessed the additional resources for symptom management. | Baseline - 16 weeks |
| Acceptability of Accessing Additional Resources for Symptom Management |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acceptability will be measured by whether participants accessed the additional resources for symptom management. |
| Baseline - 16 weeks |
| Symptom Severity | Symptom severity will be measured through the Edmonton Symptom Assessment System (ESAS). The survey is 10 questions assessing the severity of pain, nausea, depression, etc. on a 0 to 10 scale-in which a 0 representing best possible state/symptom absence and a 10 representing worst possible state. | Baseline - 16 weeks |
| Medication Use | Medication use will be measured through a medication diary created for the study. The medication diary asks participants about recent medications, amounts, and dosages. | Baseline - 16 weeks |
| Hospital-Free Days | Hospital-free days will be measured through examination of participant's electronic health record. | Baseline - 16 weeks |
| Mortality | Mortality will be measured through examination of participant's electronic health record. | Baseline - 16 weeks |